SCHEMBL3263663

SCHEMBL3263663

O=C(c1ccccc1)c1cc2ccccc2o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 1.00
RAB9A P51151 5/20 1.00
MAPK1 P28482 3/20 1.00
TSHR P16473 2/20 1.00
MEN1 O00255 1/20 1.00
KMT2A Q03164 1/20 1.00
FLT3 P36888 2/20 0.79
MAPT P10636 5/20 0.76
SMN1; SMN2 Q16637 4/20 0.76
ALDH1A1 P00352 3/20 0.76
HPGD P15428 2/20 0.76
STK17B O94768 1/20 0.69
CASP3 P42574 1/20 0.67
SENP8 Q96LD8 1/20 0.67
SENP7 Q9BQF6 1/20 0.67
SENP6 Q9GZR1 1/20 0.67
HDAC3 O15379 2/20 0.61
HDAC4 P56524 2/20 0.61
HDAC1 Q13547 2/20 0.61
HDAC7 Q8WUI4 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14124819 0.91 NPC1 (0.84) NPC1RAB9AMAPK1TSHRMEN1
SCHEMBL11109735 0.90 NPC1 (0.81) NPC1RAB9AMAPK1TSHRMEN1
SCHEMBL244107 0.88 FLT3 (1.00) NPC1RAB9AMAPK1TSHRMEN1
SCHEMBL31061078 0.88 FLT3 (1.00) NPC1RAB9AMAPK1TSHRMEN1
SCHEMBL11843224 0.88 NPC1 (0.78) NPC1RAB9AMAPK1TSHRMEN1
SCHEMBL19380254 0.88 NPC1 (0.78) NPC1RAB9AMAPK1TSHRMEN1
SCHEMBL8761650 0.86 NPC1 (1.00) NPC1RAB9AMAPK1TSHRMEN1
SCHEMBL8708182 0.86 NPC1 (0.76) NPC1RAB9AMAPK1TSHRMEN1
SCHEMBL2507064 0.86 NPC1 (0.76) NPC1RAB9AMAPK1TSHRMEN1
SCHEMBL29848148 0.86 NPC1 (0.76) NPC1RAB9AMAPK1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2859069-B1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2020-10-14 EP claimed
CN-108484546-A A kind of preparation method of 2- methyl -3- benzoyl benzofuran derivatives 江南大学 2018-09-04 CN claimed
US-9328300-B2 Method, apparatus and chemical products for treating petroleum equipment FERRARA MARCELLO (IT) 2016-05-03 US claimed
EP-2859069-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT Ferrara, Marcello (IT) 2015-04-15 EP claimed
WO-2013156228-A1 METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-24 WO claimed
US-20130270157-A1 METHOD, APPARATUS AND CHEMICAL PRODUCTS FOR TREATING PETROLEUM EQUIPMENT FERRARA MARCELLO (IT) 2013-10-17 US claimed
WO-1995020637-A2 HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) 1995-08-03 WO claimed
US-12421257-B2 Compositions and methods for inhibiting group II intron RNA YALE UNIVERSITY (US) 2025-09-23 US disclosed
US-20240018169-A1 COMPOSITIONS AND METHODS FOR INHIBITING GROUP II INTRON RNA UNIV YALE (US) 2024-01-18 US disclosed
CN-117105891-A Synthesis method of benzofuran compound promoted by DBDMH 河南科技大学 2023-11-24 CN disclosed
US-11739104-B2 Compositions and methods for inhibiting group II intron RNA YALE UNIVERSITY (US) 2023-08-29 US disclosed
WO-2023149549-A1 NOVEL PHARMACEUTICAL COMPOSITION 国立大学法人富山大学 2023-08-10 WO disclosed
CN-112812084-B Synthetic method of benzofuran compound 温州大学新材料与产业技术研究院 2022-08-09 CN disclosed
US-4094845-A PLANTS, CARBOXYLATED HYDROPHILIC ACRYLIC POLYMER, CROSSLINKING AGENT AND AN ULTRAVIOLET ABSORBER UNITED STATES TRADING INTERNATIONAL, INC. (US) 1978-06-13 US disclosed
US-4082884-A METHOD OF REDUCING FOULING OF MARINE STRUCTURES AND COATED STRUCTURE THEREOF UNITED STATES TRADING INTERNATIONAL, INC. (US) 1978-04-04 US disclosed
US-4049869-A CROSSLINKING A CARBOXYLATED HYDROPHILIC ACRYLIC POLYMER UNITED STATES TRADING INTERNATIONAL, INC. (US) 1977-09-20 US disclosed
US-4024273-A Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity SMITHKLINE CORPORATION (US) 1977-05-17 US disclosed
US-4001426-A HAVING CORONARY VASODILATOR ACTIVITY SMITHKLINE CORPORATION (US) 1977-01-04 US disclosed
US-4001426-A HAVING CORONARY VASODILATOR ACTIVITY SMITHKLINE CORPORATION (US) 1977-01-04 US disclosed
US-3947470-A CORONARY VASODILATORS, TREATMENT OF ANGINA PECTORIS SMITHKLINE CORPORATION (US) 1976-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12421257-B2 Compositions and methods for inhibiting group II intron RNA NSUN2, RBM22, RNGTT NPC1 1290/4885RAB9A 3888/4885MAPK1 4213/4885
US-11739104-B2 Compositions and methods for inhibiting group II intron RNA NSUN2, RBM22, RNGTT NPC1 1290/4885RAB9A 3888/4885MAPK1 4213/4885
US-20240018169-A1 COMPOSITIONS AND METHODS FOR INHIBITING GROUP II INTRON RNA NSUN2, RBM22, RNGTT NPC1 1290/4885RAB9A 3888/4885MAPK1 4213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.